H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA), recently conducted an inspection tour of the Authority’s Eastern Province branch, visiting several affiliated facilities.

The Saudi Food and Drug Authority (SFDA) seized 571 unlicensed facilities engaged in the manufacture and storage of food, medicines, and medical devices in the regions of Makkah and Madinah, referring the violating establishments to the competent authorities for legal action.

The SFDA explained that it conducted 3,676 inspection visits to the facilities under its supervision during intensive supervisory tours as part of its role during the Hajj season, ensuring the safety of food, medicines, and medical products.

The Saudi Food and Drug Authority (SFDA) detected 187 violating facilities and 277 types of products during 1,959 monitoring and inspection tours conducted across all regions of the Kingdom in May 2024.

The Saudi Food and Drug Authority (SFDA), in cooperation with the Chamber of Commerce in Jazan, is organizing a workshop entitled "Safe Use of Medical Devices within Health Care Facilities" at the headquarters of the Chamber tomorrow. Through this workshop, the SFDA seeks to promote the safe use of medical devices and supplies and clarify the complementary role between the National Center for Medical Devices and Supplies Reporting (NCMDR) and health care providers.

The Saudi Food and Drug Authority (SFDA) has issued an awareness guide for the most commonly used home medical devices and supplies. This guide includes detailed information on how to use these devices safely and general alerts for their proper handling.

The Saudi Food and Drug Authority (SFDA), in collaboration with the Riyadh Chamber, hosted a workshop titled "Standard Specifications for Medical Devices and Supplies" on Wednesday, November 13, 2024. The event was attended by approximately 50 representatives from local manufacturing companies.

In the Chinese capital, Beijing, the Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding (MoU) today, Friday, with China’s National Medical Products Administration (NMPA) to exchange experiences and regulatory information.

The MoU was signed by the Chief Executive Officer of the SFDA, H.E. Dr. Hisham S. Aljadhey, and the Commissioner of the NMPA, H.E. Mr. Li Li, at the NMPA headquarters, in the presence of H.E. Mr. Abdulrahman Al-Harbi, Saudi Arabia’s Ambassador to China.

The Saudi Food and Drug Authority (SFDA) is proud to announce joining the International Medical Device Regulators Forum (IMDRF). This strategic move reflects the SFDA's commitment to fostering collaboration and alignment with international standards and practices in the regulation of medical devices, based on its Fourth Strategy, which aims to enhance international leadership.